Current filters:  
Europe
Healthcare
Life Sciences, Biotechnology & Nanotechnology
Austria
Schoenherr Attorneys at Law
Austria's healthcare system got a long-anticipated makeover. After years of small-scale adjustments, a collective amendment – the "Vereinbarungsumsetzungsgesetz 2024"...
Belgium
Altius
For the past five years there has been an ongoing battle between the Belgian Competition Authority ("BCA") and the legislator about the BCA's competence...
Denmark
Plesner
From 1 April 2024, pharmaceutical companies must agree on an application date with the Danish Medicines Council's secretariat when they want an assessment of a new medicinal product.
Germany
Bardehle Pagenberg
Counterclaim for revocation can be combined with central revocation action against the same patent upon request by the parties
Kazakhstan
GRATA International
Как отмечалось нами ранее в предыдущих обзорах нормативно-правового регулирован&
GRATA International
As previously noted in our earlier reviews of regulatory legislation in the healthcare sector, the legislative framework is subject to dynamic changes, particularly in the regulation and pricing of medicines.
Netherlands
Taylor Wessing
The case law year started well for those interested in supplementary protection certificates ("SPCs") for patents and waivers thereof: on 23 January 2024...
Switzerland
MME
Narcosis, whippped cream, engine tuning or party drug: laughing gas has many uses in Switzerland. But what is the legal classification of laughing gas...
Lenz & Staehelin
On March 10 2024, Switzerland – together with fellow European Free Trade Association members Liechtenstein, Norway and Iceland – signed the ‘Trade and Economic Partnership Agreement' with India.
Kellerhals Carrard
What are important changes in regulation and what is to be expected from the markets in 2024? The co-heads of Kellerhals Carrard's Life Sciences Practice Group share their perspective on key developments.
Turkey
Gun + Partners
1262 sayılı İspençiyari ve Tıbbi Müstahzarlar Kanunu ("1262 sayılı Kanun") ile 3359 sayılı Sağlık Hizmetleri Temel Kanunu'nundaki ("3359 sayılı Kanun") klinik araştırma hükümlerinde değişiklik...
UK
Withers LLP
The landscape of innovation continues to evolve as we advance through 2024, pushing boundaries and redefining what is possible in both the technology and sustainability sectors.
Keltie LLP
On 23 March 2023, the European Patent Office (EPO) Enlarged Board of Appeal (EBA) published its decision in case G 2/21, concerning plausibility in patent applications.
HLK
The Patents Court has provided useful clarity regarding the different roles of technical experts and scientific advisers in English patent actions.
WTW
External forces are creating an urgent need for change in rewards approach. See how sector organizations are responding.
Withers LLP
The products and innovations of life sciences businesses make an essential contribution to the health and quality of life of us all.
European Union
Kromann Reumert
Welcome to this edition of Kromann Reumert's Life Science Update. In the following, we provide an overview of recent legal updates that will have a bearing on the life science industry across Europe...
Arnold & Porter
This digest covers key virtual and digital health regulatory and public policy developments during February 2024.
Worldwide
Herbert Smith Freehills
After a relatively flat start, activity picked up in the second half of the year with a flurry of sizeable transactions announced including AbbVie's acquisitions of Cerevel and ImmunoGen...
Gowling WLG
Earlier this month, the UK signed an agreement on closer trade co-operation with Texas as the Government continues talks over a Free Trade Agreement at a federal level.
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Popular Contributors
Upcoming Events
Mondaq Social Media